<DOC>
	<DOC>NCT00095511</DOC>
	<brief_summary>The purpose of this trial is to test the safety &amp; efficacy of aripiprazole in patients with Bipolar Mania for a period of at least 12 weeks.</brief_summary>
	<brief_title>Aripiprazole in Patients With Acute Mania</brief_title>
	<detailed_description />
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Aripiprazole</mesh_term>
	<criteria>Primary diagnosis of Acute Bipolar I Mania Patients with a DSMIV diagnosis other than Bipolar I Mania</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2008</verification_date>
	<keyword>Bipolar Mania</keyword>
</DOC>